| abstract |
A substituted triazolopyridazine derivative, its use in therapy, compositions containing it and processes for its manufacture are disclosed. 3-(5-Methylixoxazol-3-yl)-6-(1-methyl-1,2,3-triazol-4-yl)methyloxy-1,2,4-triazolo[3,4-a]phthalazine. A pharmaceutical composition for use in treating a dementing illness comprising the compound as described in claim 1 and a pharmaceutically acceptable carrier. |